Zanubrutinib in Patients With Waldenstr öm's Macroglobulinemia (ARIADNE)
Condition: Waldenström's Macroglobulinemia Intervention: Drug: Zanubrutinib Sponsors: iOMEDICO AG; BeiGene Switzerland GmbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials